1932

Abstract

Significant advances in magnetic resonance imaging (MRI) technology and treatment of multiple sclerosis (MS) have been made during the past decade. These advances have revealed evidence of profound heterogeneity in MS. There is a clear need to revisit the key issues in MS pathogenesis and treatment strategies, taking new data into consideration. This paper provides an overview of recent progress in MS research, including () a review of clinical, pathologic, and immunologic aspects of MS, () a discussion of the mechanism of action of currently available disease-modifying drugs for MS, () an account of the role of MRI in clinical management and clinical trials in MS, and () an overview of some emerging treatments for MS.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.56.082103.104739
2005-02-18
2024-06-18
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.56.082103.104739
Loading
/content/journals/10.1146/annurev.med.56.082103.104739
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error